Cardiac Transplant Terminated Phase 2 Trials for Bortezomib (DB00188)

Also known as: Heart Transplant / Heart Transplantation

IndicationStatusPhase
DBCOND0030027 (Cardiac Transplant)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01769443Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart TransplantationTreatment